Dewei Jiang

7PUBLICATIONS
11CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 08, 2025
A novel peptide 66CTG stabilizes Myc proto-oncogene protein to promote triple-negative breast cancer growth.

Huichun Liang, Fubing Li, Huan Fang

|Nov 02, 2024
Targeting the HECTD3-p62 axis increases the radiosensitivity of triple negative breast cancer cells.

Maobo Huang, Wenjing Liu, Zhuo Cheng

|Dec 23, 2022
RNF126-Mediated MRE11 Ubiquitination Activates the DNA Damage Response and Confers Resistance of Triple-Negative Breast Cancer to Radiotherapy.

Wenjing Liu, Min Zheng, Rou Zhang

|Aug 02, 2022
Targeting HECTD3-IKKα axis inhibits inflammation-related metastasis.

Fubing Li, Huichun Liang, Hua You

|Jan 13, 2022
YB-1 is a positive regulator of KLF5 transcription factor in basal-like breast cancer.

Dewei Jiang, Ting Qiu, Junjiang Peng

Pageof 2